Bayer Aktiengesellschaft (ETR:BAYN) Trading Down 1.3% – Time to Sell?

Shares of Bayer Aktiengesellschaft (ETR:BAYNGet Free Report) fell 1.3% during trading on Tuesday . The stock traded as low as €19.22 ($20.02) and last traded at €19.50 ($20.31). 4,583,339 shares traded hands during trading, The stock had previously closed at €19.76 ($20.58).

Bayer Aktiengesellschaft Stock Down 0.6 %

The firm has a fifty day moving average price of €22.40 and a 200 day moving average price of €25.70. The company has a quick ratio of 0.72, a current ratio of 1.27 and a debt-to-equity ratio of 129.94. The company has a market cap of $18.88 billion, a P/E ratio of -14.90, a PEG ratio of 36.39 and a beta of 0.97.

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Featured Stories

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.